Terumo Releases a Narrower Stent-Graft for TEVAR Procedures

Terumo is launching in Europe its RelayPro Thoracic Stent-Graft System, initially being released to a limited set of institutions with wider availability expected soon. The device is designed to allow patients with narrower access vessels to benefit from thoracic endovascular aortic repair (TEVAR) procedures. It’s based on the previously (Read more...)

Shire to consider Takeda takeover deal

Shire’s board may recommend its shareholders accept a bid from the Japanese-based pharmaceutical company Takeda, Shire announced in a press release.
The proposal includes 21.75 pounds in cash and 27.26 pounds in new Takeda shares per Shire share, for a total of approximately 46 billion pounds, the release said.
Shire’s board “would be willing to recommend the revised proposal,” contingent on a resolution of other terms of the offer including an agreement of certain terms, completion of a confirmatory due diligence review, the unanimous and unconditional recommendation of

Samenvatting: Novaliq presenteert wetenschappelijk en klinisch onderzoek tijdens 2018 Association for Research in Vision and Ophthalmology Meeting in Honolulu

HEIDELBERG, Germany–(BUSINESS WIRE)–Novaliq GmbH, een gespecialiseerd farmaceutisch bedrijf met een revolutionair platform voor medicijntoediening dat slecht oplosbare geneesmiddelen verandert in effectieve oogheelkundige therapieën heeft vandaag aangekondigd dat vier wetenschappelijke posters zullen worden gepresenteerd op de bijeenkomst van de Association for Research in Vision and Ophthalmology (ARVO) in Honolulu, Hawaïi (29 april- 3 mei). De verscheidenheid aan te presenteren gegevens wee